Announced today a collaboration agreement with Eisai Inc.

announced today a collaboration agreement with Eisai Inc. on research and advancement of novel therapeutics for the treating psychiatric disorders. The multi-year collaboration shall entail pre-clinical validation of potential therapeutics leading to clinical proof-of-concept studies. In partnership with Eisai Now, Aestus will test the products to identify the very best applicants for potential subsequent advancement in scientific trials. Related StoriesLiposomal sizing and the Coulter principle: an interview with Professor Melvin E.

Blood is circulated through the dialysis machine , which removes wastes and toxins. The blood is then returned to the affected individual`s body. Most people require hemodialysis three times per week. With peritoneal dialysis, wastes and surplus drinking water from the bloodstream cross into the stomach cavity and so are eliminated from your body by coursing through a catheter that is surgically implanted in to the peritoneal cavity.Blood is circulated through the dialysis machine , which removes wastes and toxins. The blood is then returned to the affected individual`s body. Most people require hemodialysis three times per week. With peritoneal dialysis, wastes and surplus drinking water from the bloodstream cross into the stomach cavity and so are eliminated from your body by coursing through a catheter that is surgically implanted in to the peritoneal cavity.